Sapience Investments, LLC

Sapience Investments, LLC is an independent investment management firm based in Los Angeles, California, focusing on global and international equity mandates for institutional and sophisticated investors. The firm operates as a research-centric boutique, running concentrated but diversified portfolios built from bottom-up fundamental analysis, typically through separate accounts and commingled vehicles. Within the U.S. regulatory framework, Sapience Investments, LLC is an SEC-registered investment adviser and qualifies as an institutional investment manager. It files Form 13F with the Securities and Exchange Commission under CIK #1682598, disclosing its reportable long positions in U.S.-listed equities and certain equity-like securities at each calendar quarter-end. Because Sapience’s strategies are global in scope, the 13F dataset represents the U.S.-listed component of a broader international opportunity set, including both domestic issuers and U.S.-traded depositary receipts for non-U.S. companies. The firm’s 13F reports enumerate individual positions—issuers, share counts, and quarter-end market values—but do not include non-U.S. securities that are not U.S.-listed, fixed income, derivatives, short positions, cash, or intra-quarter trading. On an analytics platform, all filings tied to CIK #1682598 can be organized into a continuous 13F History for Sapience Investments, LLC, creating a structured basis for analyzing its disclosed long-equity sleeve over time.

Sapience Investments, LLC pursues a fundamentally driven, value-oriented equity approach with a quality and GARP (growth at a reasonable price) overlay. The investment philosophy emphasizes owning durable businesses trading at discounts to intrinsic value, with a strong focus on downside protection and long-term capital compounding rather than benchmark tracking. Key elements of the approach include: - Business quality and resilience: Preference for companies with defensible competitive advantages, solid balance sheets, prudent capital allocation, and sustainable cash-flow generation. - Valuation discipline: Investments are made when securities trade at a margin of safety to the firm’s estimate of intrinsic value, typically avoiding highly speculative or momentum-driven names. - Global, benchmark-agnostic opportunity set: Portfolios draw from developed and selected emerging markets, with country and sector weights emerging from bottom-up stock selection rather than top-down macro calls. - Concentration and long horizon: Capital tends to be allocated to a focused list of high-conviction ideas, with holding periods often measured in years rather than quarters. Within the Form 13F context, this philosophy typically manifests as a portfolio of 20–50 U.S.-listed positions (including ADRs) that span sectors such as industrials, financials, consumer, technology, and healthcare. The mix tends to lean toward companies where valuation, balance sheet strength, and identifiable catalysts combine to create asymmetric risk/reward profiles. A longitudinal review of Sapience’s 13F Portfolio Composition allows allocators to see how these ideas translate into practical exposures: the concentration of the top holdings, the evolution of sector weights, and the balance between U.S. domestics and international ADRs. When the full 13F filing history is fed into a Portfolio Simulator or Backtesting Service, users can construct a long-only replication of Sapience’s disclosed U.S.-listed book, enabling a systematic study of how this subset of the strategy would have compounded through time.

Sapience Investments, LLC appears in the 13F universe as a Los Angeles–based, research-intensive global equity boutique with a pronounced value and quality orientation. Its filings under CIK #1682598 provide a recurring, position-level record of how that philosophy is expressed in U.S.-listed securities and ADRs. By aggregating these filings into a unified dataset, an analytics platform can construct a 13F-based Historical Track Record that mirrors a portfolio holding Sapience’s disclosed positions between quarter-ends. Examining the evolution of this reconstructed capital trajectory alongside changes in 13F Portfolio Composition—sector balance, geographic mix via ADRs, and concentration in core names—gives allocators a clearer sense of how the U.S.-listed sleeve of Sapience’s strategies has behaved through different equity regimes. Overlaying risk diagnostics such as Max Drawdown Depth and a holdings-derived Sharpe Ratio adds depth to this picture by quantifying the variability and risk-adjusted characteristics of the reconstructed book. Because these insights are drawn solely from public 13F data, they are best viewed as a complementary, data-driven lens on Sapience’s practice rather than a substitute for mandate-level discussions. The key open question for allocators is how the regime sensitivity implied by this 13F-based reconstruction—across value vs. growth cycles, risk-on/risk-off environments, and periods of stress in smaller-cap and international equities—maps onto the behavior of Sapience Investments, LLC’s full global portfolios over time.

Sapience’s risk posture, as inferred from public information and its 13F filings, is that of a concentrated, fundamentals-based global equity manager with a pronounced value and quality tilt. At the mandate level, risk is managed primarily through security selection—emphasizing balance sheet strength and valuation support—and through diversification across geographies and industries rather than through heavy use of derivatives. Seen through the 13F lens, key observable dimensions of risk in the U.S.-listed sleeve include: - Equity market sensitivity: The disclosed holdings collectively carry beta to global and U.S. equity markets, with realized sensitivity influenced by the mix of cyclical vs. defensive names. - Concentration risk: Capital is typically focused in a limited number of high-conviction positions, leading to non-trivial single-name and sector exposures relative to broad indices. - Factor exposures: Portfolios often exhibit tilts toward value, quality, and—depending on mandate—small- and mid-cap segments, which can drive differentiation versus market-cap-weighted benchmarks. - Liquidity profile: While positions are generally established in listed, tradeable names, exposure to mid- and smaller-cap companies can elevate liquidity risk in stressed environments. By treating each 13F report as a quarter-end snapshot of the long U.S.-listed book and running Performance Backtests Online, an allocator can build a synthetic, long-only capital path that holds Sapience’s disclosed positions between filings. From this historical replication, it is possible to estimate volatility, downside capture in weak markets, and drawdown behavior. Metrics such as Max Drawdown Depth summarize the worst peak-to-trough contraction implied by the reconstructed sleeve, while a holdings-derived Sharpe Ratio offers a concise view of risk-adjusted outcomes for this 13F-based shadow portfolio. These analytics are necessarily partial. Form 13F omits non-U.S. securities that are not U.S.-listed, any hedging or derivative usage, cash balances, and intra-quarter trading. Consequently, the volatility and drawdown characteristics derived from 13F-based replication describe only an unhedged, U.S.-listed component of Sapience Investments, LLC’s strategies, not the firm’s complete economic exposure across all markets and instruments.